Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04013672
Brief Title: Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

First Submitted : July 8, 2019
First Submitted that Met QC Criteria : July 8, 2019
First Posted : July 10, 2019

Last Update Submitted that Met QC Criteria : March 15, 2021
Last Update Posted : March 17, 2021